MNOV (STOCKS)
Medicinova, Inc.
$1.310000
-0.020000 (-1.50%)
Prev close: $1.330000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Yuichi Iwaki
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $64.91M
- Employees
- 6
- P/E (TTM)
- -5.49
- P/B (TTM)
- 1.66
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
6
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-0.05 | $-0.07 | +0.0214 | +29.97% |
|
Dec 2025 (Q4)
|
$-0.05 | $-0.10 | +0.0469 | +48.40% |
|
Sep 2025 (Q3)
|
$-0.06 | $-0.10 | +0.0420 | +41.18% |
|
Jun 2025 (Q2)
|
$-0.07 | $-0.10 | +0.0269 | +27.76% |
Financial Statements
| Revenues | $596.64K |
| Benefits Costs and Expenses | $5.72M |
| Costs And Expenses | $12.97M |
| Operating Expenses | $13.51M |
| Research and Development | $6.10M |
| Other Operating Expenses | $7.41M |
| Operating Income/Loss | -$12.92M |
| Income/Loss From Continuing Operations After Tax | -$11.72M |
| Income/Loss From Continuing Operations Before Tax | -$8.54M |
| Net Income/Loss | -$11.72M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$11.72M |
| Net Income/Loss Available To Common Stockholders, Basic | -$11.72M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.23 |
| Diluted Earnings Per Share | -$0.23 |
| Basic Average Shares | 147,330,930 |
| Diluted Average Shares | 147,330,930 |
| Assets | $42.70M |
| Current Assets | $28.15M |
| Noncurrent Assets | $14.56M |
| Fixed Assets | $14.88K |
| Other Non-current Assets | $14.54M |
| Liabilities | $3.30M |
| Current Liabilities | $3.10M |
| Accounts Payable | $852.37K |
| Other Current Liabilities | $2.24M |
| Noncurrent Liabilities | $201.79K |
| Equity | $39.41M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $39.41M |
| Liabilities And Equity | $42.70M |
| Net Cash Flow From Operating Activities | -$9.50M |
| Net Cash Flow From Operating Activities, Continuing | -$9.50M |
| Net Cash Flow From Investing Activities | -$13.72K |
| Net Cash Flow | -$5.79M |
| Net Cash Flow, Continuing | -$5.79M |
| Comprehensive Income/Loss | -$11.72M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$11.72M |
| Other Comprehensive Income/Loss | -$3.05M |